Trials / Sponsors / Yunpeng Liu
Yunpeng Liu
Academic / Other · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcin Advanced Gastric Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Advanced Colorectal Cancer | Phase 2 | 2024-12-01 |
| Recruiting | Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer Small Cell Lung Cancer | N/A | 2024-08-09 |
| Not Yet Recruiting | Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Car Biliary Tract Carcinoma | N/A | 2024-07-01 |
| Unknown | The Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing Chemotherapy Chemotherapy-induced Nausea and Vomiting | N/A | 2018-07-12 |
| Unknown | Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeu Extensive Stage Small Cell Lung Cancer | Phase 2 | 2016-06-01 |